{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/42571-245#drug","name":"OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE","alternateName":"Olmesartan Medoxomil, Amlodipine besylate and Hydrochlorothiazide","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"42571-245"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"ANDA207437"},{"@type":"PropertyValue","propertyID":"UNII","value":"864V2Q084H|6M97XTV3HD|0J48LPH2TH"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"9fb71df8-f70f-47dc-9465-8d8748261caf"}],"activeIngredient":"AMLODIPINE BESYLATE, HYDROCHLOROTHIAZIDE, OLMESARTAN MEDOXOMIL","administrationRoute":["ORAL"],"dosageForm":"TABLET, FILM COATED","manufacturer":{"@type":"Organization","name":"Micro Labs Limited"},"drugClass":[],"isAvailableGenerically":true,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/ANDA207437","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9fb71df8-f70f-47dc-9465-8d8748261caf","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42571-245"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-01T23:47:39.740Z"}}